AAAAAA

   
Results: 1-16 |
Results: 16
CHRONIC ARTHRITIS AND GAMMA-HEAVY-CHAIN DISEASE - COINCIDENCE OR PATHOGENIC LINK
Authors: HUSBY G BLICHFELDT P BRINCH L BRANDTZAEG P MELLBYE OJ SLETTEN K STENSTAD T
Citation: G. Husby et al., CHRONIC ARTHRITIS AND GAMMA-HEAVY-CHAIN DISEASE - COINCIDENCE OR PATHOGENIC LINK, Scandinavian journal of rheumatology, 27(4), 1998, pp. 257-264
CYTOMEGALOVIRUS INFECTIONS AFTER ALLOGENEIC PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION (PBPCT) - A SURVEY OF THE INFECTIOUS-DISEASES WORKING PARTY OF EBMT
Authors: LINK H ARSENIEV L LJUNGMAN P ALESSANDRINO EP AMADORI S BANDINI G BEGUIN Y BRINCH L BRUNET S CHOPRA R CORDONNIER C DEWITTE T FAUSER A FERRANT A GARCIACONDE J JULIUSSON G KUBEL M MANNA AT MARTINEZRUBIO AM MUNDHENK P ORDEMANN R ORTEGA JJ POTTER M PRENTICE HG RAIMONDI R REMEZ K REUSSER P ROVIRA M RUSSELL J SELLESLAG D UDERZO C ZAUCHA JM
Citation: H. Link et al., CYTOMEGALOVIRUS INFECTIONS AFTER ALLOGENEIC PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION (PBPCT) - A SURVEY OF THE INFECTIOUS-DISEASES WORKING PARTY OF EBMT, Bone marrow transplantation, 21, 1998, pp. 479-479
SURVIVAL IN 86 PATIENTS, AGED 15-60, WITH PRIMARY ACUTE MYELOGENOUS LEUKEMIA, TREATED WITH A COMMON PROGRAM IN THE NORWEGIAN HEALTH REGION-I, REGION-III, REGION-IV AND REGION-V IN THE PERIOD 1990-1995
Authors: TANGEN JM ABDELNOOR M BRINCH L DAHL IM LAMVIK J LY B
Citation: Jm. Tangen et al., SURVIVAL IN 86 PATIENTS, AGED 15-60, WITH PRIMARY ACUTE MYELOGENOUS LEUKEMIA, TREATED WITH A COMMON PROGRAM IN THE NORWEGIAN HEALTH REGION-I, REGION-III, REGION-IV AND REGION-V IN THE PERIOD 1990-1995, European journal of haematology, 59(2), 1997, pp. 110-114
OUTCOME OF A MULTICENTER TREATMENT PROGRAM INCLUDING AUTOLOGOUS OR ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR DE-NOVO ACUTE MYELOID-LEUKEMIA
Authors: WAHLIN A BRINCH L HORNSTEN P EVENSEN SA OBERG G SIMONSSON B HEDENUS M
Citation: A. Wahlin et al., OUTCOME OF A MULTICENTER TREATMENT PROGRAM INCLUDING AUTOLOGOUS OR ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR DE-NOVO ACUTE MYELOID-LEUKEMIA, European journal of haematology, 58(4), 1997, pp. 233-240
NO PREVENTION OF CYTOMEGALOVIRUS-INFECTION BY ANTICYTOMEGALOVIRUS HYPERIMMUNE GLOBULIN IN SERONEGATIVE BONE-MARROW TRANSPLANT RECIPIENTS
Authors: RUUTU T LJUNGMAN P BRINCH L LENHOFF S LONNQVIST B RINGDEN O RUUTU P VOLIN L ALBRECHTSEN D SALLERFORS B EBELING F MYLLYLA G
Citation: T. Ruutu et al., NO PREVENTION OF CYTOMEGALOVIRUS-INFECTION BY ANTICYTOMEGALOVIRUS HYPERIMMUNE GLOBULIN IN SERONEGATIVE BONE-MARROW TRANSPLANT RECIPIENTS, Bone marrow transplantation, 19(3), 1997, pp. 233-236
CYTOMEGALOVIRUS INFECTIONS AFTER ALLOGENEIC PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION (PBPCT) - A SURVEY OF THE INFECTIOUS-DISEASES WORKING PARTY OF EBMT
Authors: LINK H ARSENIEV L LJUNGMAN P ALESSANDRINO EP AMADORI S BANDINI G BEGUIN Y BRINCH L BRUNET S CHOPRA R CORDONNIER C DEWITTE T FAUSER A FERRANT AF GARCIACONDE J JULIUSSON G KUBEL M MANNA A MARTINEZRUBIO AM MUNDHENK P ORDEMANN R ORTEGA JJ POTTER M PRENTICE HP RAIMONDI R REMEZ K REUSSER P ROVIRA M RUSSELL J SELLESLAG D UDERZO C ZAUCHA JM
Citation: H. Link et al., CYTOMEGALOVIRUS INFECTIONS AFTER ALLOGENEIC PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION (PBPCT) - A SURVEY OF THE INFECTIOUS-DISEASES WORKING PARTY OF EBMT, Blood, 90(10), 1997, pp. 2424-2424
OUTCOME FOR PATIENTS WITH LEUKEMIA, MULTIPLE-MYELOMA AND LYMPHOMA WHORELAPSE AFTER HIGH-DOSE THERAPY AND AUTOLOGOUS STEM-CELL SUPPORT
Authors: JOHNSEN HE BJORKSTRAND B CARLSON K GRUBER A BLYSTAD A FAST A BOESEN AM BJORKHOLM M SALLERFORS B RUUTU T CARNESKOG J MALM A GEISLER C LEHTINEN M SCHRODER H BRINCH L REMES K TIDEFELT U HEILMANN C HORNSTEN P THORLING K DAUGAARD G
Citation: He. Johnsen et al., OUTCOME FOR PATIENTS WITH LEUKEMIA, MULTIPLE-MYELOMA AND LYMPHOMA WHORELAPSE AFTER HIGH-DOSE THERAPY AND AUTOLOGOUS STEM-CELL SUPPORT, Leukemia & lymphoma, 24(1-2), 1996, pp. 81-91
DIFFERENCES IN THE DISTRIBUTION OF CD34 EPITOPES ON NORMAL HAEMO-POIETIC PROGENITOR CELLS AND LEUKEMIC BLAST CELLS
Authors: STEEN R TJONNFJORD GE GAUDERNACK G BRINCH L EGELAND T
Citation: R. Steen et al., DIFFERENCES IN THE DISTRIBUTION OF CD34 EPITOPES ON NORMAL HAEMO-POIETIC PROGENITOR CELLS AND LEUKEMIC BLAST CELLS, Experimental hematology, 24(9), 1996, pp. 83-83
TRANSPLANTATION OF ALLOGENEIC PERIPHERAL-BLOOD PROGENITOR CELLS - THEEBMT EXPERIENCE
Authors: SCHMITZ N BACIGALUPO A LABOPIN M MAJOLINO I LAPORTE JP BRINCH L COOK G LAMBERTENGHIDELILIERS G LANGE A ROZMAN C GARCIACONDE J FINKE J DOMINGOALBOS A GRATWOHL A
Citation: N. Schmitz et al., TRANSPLANTATION OF ALLOGENEIC PERIPHERAL-BLOOD PROGENITOR CELLS - THEEBMT EXPERIENCE, Bone marrow transplantation, 17, 1996, pp. 40-46
TRANSPLANTATION OF PERIPHERAL-BLOOD PROGENITOR CELLS FROM HLA-IDENTICAL SIBLING DONORS
Authors: SCHMITZ N BACIGALUPO A LABOPIN M MAJOLINO I LAPORTE JP BRINCH L COOK G DELILIERS GL LANGE A ROZMAN C GARCIACONDE J FINKE J DOMINGOALBOS A GRATWOHL A
Citation: N. Schmitz et al., TRANSPLANTATION OF PERIPHERAL-BLOOD PROGENITOR CELLS FROM HLA-IDENTICAL SIBLING DONORS, British Journal of Haematology, 95(4), 1996, pp. 715-723
DIFFERENCES IN THE DISTRIBUTION OF CD34 EPITOPES ON NORMAL HEMATOPOIETIC PROGENITOR CELLS AND LEUKEMIC BLAST CELLS
Authors: STEEN R TJONNFJORD GE GAUDERNACK G BRINCH L EGELAND T
Citation: R. Steen et al., DIFFERENCES IN THE DISTRIBUTION OF CD34 EPITOPES ON NORMAL HEMATOPOIETIC PROGENITOR CELLS AND LEUKEMIC BLAST CELLS, British Journal of Haematology, 94(4), 1996, pp. 597-605
RESULTS OF A TREATMENT PROGRAM INCLUDING AUTOLOGOUS OR ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT) FOR DE-NOVO ACUTE MYELOID-LEUKEMIA (AML)
Authors: WAHLIN A BRINCH L HORNSTEN P EVENSEN SA OBERG G SIMONSSON B HEDENUS M
Citation: A. Wahlin et al., RESULTS OF A TREATMENT PROGRAM INCLUDING AUTOLOGOUS OR ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT) FOR DE-NOVO ACUTE MYELOID-LEUKEMIA (AML), Blood, 88(10), 1996, pp. 2442-2442
DECREASED LUNG-FUNCTION IN ONE-YEAR SURVIVORS OF ALLOGENEIC BONE-MARROW TRANSPLANTATION CONDITIONED WITH HIGH-DOSE BUSULFAN AND CYCLOPHOSPHAMIDE
Authors: LUND MB KONGERUD J BRINCH L EVENSEN SA BOE J
Citation: Mb. Lund et al., DECREASED LUNG-FUNCTION IN ONE-YEAR SURVIVORS OF ALLOGENEIC BONE-MARROW TRANSPLANTATION CONDITIONED WITH HIGH-DOSE BUSULFAN AND CYCLOPHOSPHAMIDE, The European respiratory journal, 8(8), 1995, pp. 1269-1274
THE INVOLVEMENT OF CD14 IN STIMULATION OF TNF PRODUCTION FROM PERIPHERAL MONONUCLEAR-CELLS ISOLATED FROM PNH PATIENTS
Authors: SUNDAN A RYAN L BRINCH L ESPEVIK T WAAGE A
Citation: A. Sundan et al., THE INVOLVEMENT OF CD14 IN STIMULATION OF TNF PRODUCTION FROM PERIPHERAL MONONUCLEAR-CELLS ISOLATED FROM PNH PATIENTS, Scandinavian journal of immunology, 41(6), 1995, pp. 603-608
CROHN DISEASE AND THE MYELODYSPLASTIC SYNDROME
Authors: BOBERG KM BRINCH L VATN M
Citation: Km. Boberg et al., CROHN DISEASE AND THE MYELODYSPLASTIC SYNDROME, Annals of internal medicine, 122(5), 1995, pp. 395-395
INCREASING AGE AND SURVIVAL AFTER BONE-MARROW TRANSPLANT
Authors: BRINCH L EVENSEN SA ALBRECHTSEN D
Citation: L. Brinch et al., INCREASING AGE AND SURVIVAL AFTER BONE-MARROW TRANSPLANT, JAMA, the journal of the American Medical Association, 270(21), 1993, pp. 2560-2560
Risultati: 1-16 |